NCT05022901 2023-12-21
An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular Melanoma
Delcath Systems Inc.
Phase 3 Unknown
Delcath Systems Inc.
Targazyme, Inc.
Shandong Lanjin Pharmaceuticals Co.,Ltd